Skip to main content
Signal8

NORTHWEST BIOTHERAPEUTICS INC (NWBO)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Northwest Biotherapeutics, Inc. logo

Northwest Biotherapeutics, Inc.

OTC:NWBOHealthcare
-5.11%$0.1319
Mkt Cap$239M
EV-
Float1.78B
O/S1.81B
VOL4M sh
$ Vol$529K
RVOL0.90×
Inst Own0.1%
SI3.9%
Net Cash/Sh-
Dilution
Northwest Biotherapeutics, Inc. logoOTC:NWBO$0.1319-5.11%
Historical Data
DateOpenHighLowCloseVolume
Nov 20, 20260.13210.13900.12220.13193,998,398
Nov 19, 20260.14420.15000.13500.13905,147,986
Nov 18, 20260.15000.15730.14400.14513,643,198
Nov 17, 20260.14800.15280.13620.14616,363,405
Nov 16, 20260.15990.15990.14510.14624,437,443
Nov 13, 20260.16510.16600.15500.15654,764,574
Nov 12, 20260.16910.17110.16410.16512,819,582
Nov 11, 20260.16600.16850.16360.16841,477,526
Nov 10, 20260.16820.16850.16210.16681,504,625
Nov 9, 20260.16890.16980.16260.16694,661,507
Nov 6, 20260.16990.16990.16200.16654,304,179
Nov 5, 20260.17000.17180.16010.16487,316,281
Nov 4, 20260.17100.18460.15710.16508,110,834
Nov 3, 20260.17450.17580.16750.16922,182,414
Nov 2, 20260.17200.17680.16000.17593,249,850
Oct 30, 20260.16840.17740.16600.17003,080,258
Oct 29, 20260.16840.16990.16510.16853,977,536
Oct 28, 20260.16150.17000.16150.16682,299,920
Oct 27, 20260.16890.17000.16100.16155,926,225
Oct 26, 20260.15430.16950.14700.16757,638,072
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
0
HOLD
1
SELL
0
TOTAL1
Insider Trades
InsiderTypeShares
BOYNTON ALTON L profile photoBOYNTON ALTON LWithholding/Transfer1.00M
MALIK NAVID profile photoMALIK NAVIDSale150.0K
MALIK NAVID profile photoMALIK NAVIDSale295.0K
MALIK NAVID profile photoMALIK NAVIDSale125.0K
BOYNTON ALTON L profile photoBOYNTON ALTON LWithholding/Transfer6.79M
Shareholders
0.1%
Institutional
(6)
0.0%
Insiderⓘ
(1)
0.0%
5%+ Owners
(0)
99.9%
Unattributed (incl. retail)ⓘ
Institutional0.1%
Insider0.0%
Unattributed (incl. retail)99.9%
Sources: 13F, Form 4O/S: 1.8B · as of 10 Nov 2026 · SEC filings
Insiders & Institutional Holders
About

Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulate their immune system to combat cancerous cells.

The company's leading therapeutic candidate, DCVax-L, has successfully completed Phase III clinical trials targeting Glioblastoma multiforme, an aggressive form of brain cancer.

Additionally, Northwest Biotherapeutics is progressing DCVax-Direct through Phase I/II clinical studies, focusing on the treatment of inoperable solid tumors. Founded in 1996, the company's headquarters are situated in Bethesda, Maryland.

Key Metrics
Market Cap$239.00M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.10%

based on 1.81B shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateDec 14, 2001
Shares Outstanding1.81B
Authorized Shares
Float1.78B
52-Week Range
$0.1222$0.3389
$0.1319(4th percentile)
Volume
Average Daily Volume4.43M
4.00M today vs 4.43M avg(-10%)

30d Avg

4.43M

60d Avg

4.90M

90d Avg

4.50M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of NWBO as of Sep 30, 2026 records an effective S-3 shelf registration (effective Nov 25, 2025), 1 outstanding warrant series and an offering closed Sep 8, 2026, from SEC filings. Northwest Biotherapeutics Inc. (OTC: NWBO) traded at $0.1319 on Nov 20, 2026, down 5.11% from the previous close of $0.1390. 52-week range: $0.1222 to $0.3389. The company is in the Healthcare sector (Biotechnology).